New ultrasound contrast agent could spot liver cancer sooner
Diagnosis
Not yet recruiting
This study will test whether using a contrast agent called Sonazoid during ultrasound can find early-stage liver cancer better than standard ultrasound alone. About 556 adults with liver cirrhosis will be scanned every 4 to 6 months. The goal is to see if this method catches more…
Phase: NA • Sponsor: Tianjin Third Central Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC